Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Shares withheld for taxes President & CEO gave up 2,015 shares (to pay taxes)
  2. 4 Grant or award Chief Medical Officer acquired 8,084 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 7,920 shares (grant or award)
  4. 4 Grant or award Chief Scientific Officer acquired 3,859 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 11,674 shares (grant or award)
  6. 4 Shares withheld for taxes President and CEO gave up 2,015 shares (to pay taxes)
  7. 4 Shares withheld for taxes President and CEO gave up 2,015 shares (to pay taxes)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy 10% owner bought 1,500,000 shares at $7.54 ($11,310,000)
  15. 4 Shares withheld for taxes President and CEO gave up 2,015 shares (to pay taxes)
  16. 4 Open-market buy 10% owner bought 1,303,636 shares at an average $8.74 ($11,395,493)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale 10% owner sold 200,000 shares at an average $4.79 ($957,100)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 13 of 34 · 674 filings